Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Combining serologic biomarkers with the PAGE B score improves risk stratification for hepatocellular carcinoma development among chronic hepatitis B patients
Scientific Reports
December 2025
Stec M.
Open Access
PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study
Hepatology International
August 2024
Gao H.
Open Access
Optimizing care of HBV infection and HBV-related HCC
Clinical Liver Disease
June 2024
Lee S.Y.
All Open Access, Green
Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review
Current Pharmaceutical Design
2024
Sharma K.K.
Characterization of Gla proteoforms and non-Gla peptides of gamma carboxylated proteins: Application to quantification of prothrombin proteoforms in human plasma
Analytica Chimica Acta
15 December 2023
Singh D.K.
All Open Access, Green
DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma
Cancers
September 2023
Lu C.Y.
Open Access
The role of PIVKA-II in hepatocellular surveillance in an Asian population
Annals of the Academy of Medicine Singapore
February 2023
Ng W.Y.
Open Access
Protein Induced by Vitamin K Absence or Antagonist-II Versus Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
Journal of Clinical Medicine Research
2023
Kobeissy A.
Open Access
A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus
Journal of Genetic Engineering and Biotechnology
December 2021
Omran M.M.
Open Access
New thresholds for afp and des-γ-carboxy prothrombin in chronic liver disease depending on the use of nucleoside analogs and an integrated nomogram
International Journal of General Medicine
2021
Sun T.
Open Access
Advances in the early diagnosis of hepatocellular carcinoma
Genes and Diseases
September 2020
Wang W.
Open Access
A Novel LC-MS/MS Assay for Quantification of Des-carboxy Prothrombin and Characterization of Warfarin-Induced Changes
Clinical and Translational Science
1 July 2020
Basit A.
Open Access
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
Plos One
1 February 2020
Zhang J.
Open Access
Screening strategy for primary hepatocellular carcinoma based on different combinations of protein induced by vitamin K absence or antagonist - II,alpha - fetoprotein,and alpha - fetoprotein - L3
Journal of Clinical Hepatology
September 2019
Xie F.
Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
World Journal of Clinical Cases
1 June 2019
Balaceanu L.A.
Open Access
The value of combined detection of Pivka-II, AFP and AFP-L3 in the diagnosis of hepatocellular carcinoma
Acta Medica Mediterranea
2019
Pan Y.
Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis
Hepatobiliary and Pancreatic Diseases International
December 2018
Xing H.
PIVKA-II as a potential new biomarker for hepatocellular carcinoma - A pilot study
In Vivo
November-December 2018
Svobodova S.
Open Access
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis
Scandinavian Journal of Gastroenterology
3 June 2018
Caviglia G.P.
All Open Access, Green
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
Cancer Management and Research
2018
Chen H.
Open Access
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data
BMC Cancer
1 September 2017
Yu R.
Open Access
Diagnostic value of prothrombin induced by the absence of Vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
Infectious Agents and Cancer
23 August 2017
Wang X.
Open Access